Clinical Trials Directory

Trials / Completed

CompletedNCT00595543

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
166 (estimated)
Sponsor
Bp Consulting, Inc · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.

Conditions

Interventions

TypeNameDescription
DRUGBromfenac1 drop (in the eye) Instill one drop in the affected eye twice daily for three months
DRUGKetorolac1 drop (in the eye) Instill one drop in the affected eye four times daily for three months
DRUGDiclofenac1 drop (in the eye) Instill one drop in the affected eye four times daily for three months

Timeline

Start date
2008-01-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2008-01-16
Last updated
2009-03-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00595543. Inclusion in this directory is not an endorsement.

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tr (NCT00595543) · Clinical Trials Directory